Dr. Ann Marie Vaughan is the Chair of the Board of Directors of Ontario Genomics.

Dr. Ann Marie Vaughan is President and CEO of Humber College Institute of Technology & Advanced Learning. She is the first woman to hold the position and is the fifth President and CEO in Humber’s history. Dr. Vaughan is a highly distinguished senior executive with nearly 30 years of success in the postsecondary sector. She joins Humber from Loyalist College in Belleville, Ontario where she served as President and CEO since 2016, and successfully drove an ambitious growth plan that strengthened Loyalist’s financial positioning, and saw the College take on a new strategic direction Prior to that she was the president and CEO of the College of the North Atlantic, in Newfoundland and Labrador, from 2011-2016. In 2015, she was recognized as a Top 50 CEO in Atlantic Canada.

Driven by her passion to advance social and economic development through expanding access to education, Dr. Vaughan is helping to pioneer the sector’s micro-credential movement as co-Chair of eCampusOntario’s Board of Directors. In addition, she serves on the Board of Directors for Ontario Genomics, a non-profit organization that is focused on nurturing genomics innovation in Ontario, and applying these technologies across key sectors, such as health, agriculture, bioproducts, and environment, to advance the province’s knowledge-based economy. Dr. Vaughan’s forward-thinking approach and significant contributions to the evolution of online learning have earned numerous accolades nationally and internationally, including being selected as a participant in the 2004 Governor General Canadian Leadership Conference.

In 2018, Dr. Vaughan was appointed to serve as an Honorary Colonel in the Royal Canadian Air Force, affiliated with the 426 Training Squadron, 8 Wing, CFB Trenton. Dr. Vaughan is actively engaged in the college sector and currently also serves as Chair of the Management Board for College Employers Council.

Dr. Vaughan is proud of her early roots in student leadership which sparked her interest and career in higher education. She holds a Bachelor of Arts and a Bachelor of Education from Memorial University; certificates in Public Administration and Business from Memorial University; a Master of Arts in Higher Education from the University of British Columbia, and a Masters Certificate in Project Management from York University/Memorial University. Continuing her lifelong learning journey, in 2015 Dr. Vaughan received her doctorate in higher education leadership from the University of Calgary.

Nancy Carter is a member of the Board of Directors of Ontario Genomics and is Chair of the Audit Committee.

Nancy is an accomplished executive, a mentor, and a consultant. She was formerly the Vice President, Legal and Corporate Governance of CANARIE Inc., a key partner in Canada’s National Research and Education Network. Prior to her VP role, she served as CANARIE’s Chief Financial Officer for 15 years. Her broad experience includes corporate finance, legal, governance, risk management, and compliance.

Nancy serves on the Board of Trustees of the American Registry for Internet Numbers (ARIN), chairing the Finance Committee, and is the former Treasurer of the Board of Directors for the Internet Society, Canada Chapter. Nancy has served on the CIRA Nomination Committee, since 2018, acting as Chair since 2020. In addition, she has participated on the Steering Committee for the Canadian Internet Governance Forum since 2018.

Tom was previously the President and CEO of Ontario Centres of Excellence for 10 years. His background includes over 40 years of experience in the venture capital, start-up, technology transfer, entrepreneurship, and academic sectors. Tom is a leader in bridging together the worlds of entrepreneurship, academia, financing, and industry.

Prior to joining OCE in 2010, Tom was CEO of the Accelerator Centre and AVP – Commercialization at the University of Waterloo. Prior to joining the University of Waterloo, he served as Director of Technology Transfer at the University of Toronto – Innovations Foundation. Before joining the University of Toronto, he spent 25 years in the private sector as an entrepreneur and as an executive with several major international technology corporations.

He holds a Doctor of Business Administration degree from Henley Management College/Brunel University in England, an MBA from the University of Toronto, the ICD.D designation from the Institute of Corporate Directors and an Advanced Post-Graduate Diploma in Management Consultancy from Henley Management College.

Tom currently also serves on the boards of C-FER Technologies (Alberta Innovates), Ontario Centre of Innovation, Tyromer Inc, Sudbury Neutrino Observatory Laboratory (SNOLAB) and AI Partnerships Corp.

Colin Kelleher is the Vice-Chair of the Board of Directors of Ontario Genomics and is also Chair of the Private Sector Advisory Committee (PSAC).

Colin is a serial entrepreneur specializing in angel investing in early-stage technology start-ups. His current investments are in digital agriculture, e-retailing, energy informatics and analytics, medical devices and municipal water analytics, efficiency and compliance software.

His earlier deals included investments in energy optimization technology, sustainable water technology and asset management modelling sustainability software for municipalities and utilities.

Colin was a partner and Chief Financial Officer of the Helyar Group, a leader in development cost management consulting. In 2005, he co-led the merger of the Helyar Group, the Altus Group and one other company to create one of the largest most comprehensive real estate consulting firms in North America. Subsequently, as co-lead, Colin took the new entity public on the Toronto Stock Exchange.

Colin holds a Bachelor of Science in Surveying from Trinity College and a Diploma in Construction Economics from Bolton Street College of Technology, both in Dublin, Ireland.

He is also a LEED-certified professional (Leadership in Energy and Environmental Design) and a member of the global Royal Institution of Chartered Surveyors.

Colin also graduated from the executive program at Singularity University, where he received the Singularity Prototype Challenge Award for his presentation on “Buildings of the Future”.

Dr. Alex MacKenzie, an attending pediatrician at the Children’s Hospital of Eastern Ontario (CHEO) has served as the CEO and Science Director of the CHEO Research Institute as well as Vice President of Research for both CHEO and Genome Canada in addition to being founding scientist of the AeGera biotech company. Dr. MacKenzie’s laboratory has conducted translational research on the rare pediatric disorder spinal muscular atrophy over the past 25 years; in recent years has broadened its focus with its involvement in the enhance Care for Rare project to search for therapies for a larger number of rare diseases.

Derek is the Assistant Vice-President, Innovation, Partnerships, and Entrepreneurship at The University of Toronto (U of T).  He supports the university’s bold innovation agenda towards fostering the next generation of Canadian entrepreneurs, developing successful corporate research partnerships, and managing the IP portfolio of the university.

U of T is a global leader in turning research into products, services, companies and jobs. In the past several years, companies emerging from U of T have secured more than $1.5 billion in investment and capital and the university is ranked among the top 10 university-managed start-up incubators in the world.

Derek held previous senior roles at Western University, he worked at a large biotechnology funding organization and also at a management consultancy firm specializing in biotechnology. He holds a PhD from U of T in biomedical research.

Dr. Benjamin Rovinski has 28 years of investment, operational, managerial and research experience in the healthcare sector. Beni joined Lumira Ventures in 2001, where he is a Managing Director, with an investment focus on early-to late-stage private and public life sciences companies. With a proven track record of delivering results both as a senior scientist and a business executive, Beni has held several senior management positions in the biotechnology sector, including 13 years at Sanofi Pasteur (formerly Aventis Pasteur) where he was a senior scientist and director of molecular virology, with a particular focus in the areas of virology, vaccine development, recombinant protein production, and functional genomics. While at Aventis, Beni led global research and development programs in the areas of HIV/AIDS and therapeutic cancer vaccines, bringing several of them through to clinical stage.

Beni received a PhD in biochemistry from McGill University in Montréal and did post-doctoral studies in molecular oncology and retrovirology at the Ontario Cancer Institute in Toronto. He obtained his undergraduate degree from Rice University in Houston. Beni’s current and past board roles and investment responsibilities include several private and public companies, including G1 Therapeutics (NASDAQ: GTHX); Aurinia Pharmaceuticals (NASDAQ:AUPH); Vascular Pharmaceuticals; KAI Pharmaceuticals (acquired by Amgen); Morphotek (acquired by Eisai); Cervelo Pharmaceuticals; Health Hero Network (acquired by Bosch); Avalon Pharmaceuticals (NASDAQ: AVRX; acquired by Clinical Data, Inc.); Inovise Medical, Inc.; Protana; Signature Biosciences; and SGX Pharmaceuticals (NASDAQ: SGXP; acquired by Eli Lilly). He also serves on the board of directors of Life Sciences Ontario and the advisory board of the TO Health! industry-led initiative to promote the profile of the Toronto region’s Human Health & Sciences cluster. Beni has published over 25 scientific articles and reviews and is the recipient of 32 issued patents.

Lyndal Walker is currently the General Manager of Sun Pharma Canada’s Branded Business.

As General Manager, Walker oversees the company’s increasing market investment and expansion of its wide range of medicines, particularly in dermatology, ophthalmology and oncology. Walker is focused on optimizing the power of Sun Pharma’s people, innovative products, global network, and localized research, to accelerate Sun Pharma’s growth in Canada. With over 25 years of experience in global healthcare and the pharmaceutical industry, she continues to unlock value for Canadians and address the unmet needs and gaps in the healthcare system. Ms. Walker has an entrepreneurial track record, starting three innovative pharmaceutical company affiliates in Canada and building teams over the past 15 years for multinational pharmaceutical companies. These include Abraxis Bioscience Inc. now part of BMS, Ipsen and Advanced Accelerator Canada Inc, a Novartis company.

Before becoming the General Manager of Sun Pharma Canada, Walker held other leadership positions in Canada and internationally. These roles included Asia Pacific Region Lead, Global Launches, North American executive team member, and Global Chief of Staff for Specialty Care with French biopharmaceutical company Ipsen, based in the UK. She also served as a board member of BIOTECanada. Currently, Walker is on the board of Ontario Geonomics.

A graduate of the University of Windsor with a degree in science, she attended the Executive Master’s program at INSEAD Business School in France.  Walker also received past training as a registered nurse in Canada and Australia.

Dr. Alan Winter is a member of the Board of Directors of Ontario Genomics and is Chair of Governance, HR and Nominations Committee.

Dr. Winter was appointed as BC’s Innovation Commissioner from 2018 to 2020.

Alan has wide experience at senior levels in the technology sector and in government, including such roles as the President and CEO of Genome BC from 2001 to 2016, the founding President and CEO of the New Media Innovation Centre in Vancouver, the President of the ComDev Space Group in Ontario, and the President and CEO of MPR Teltech Ltd. in Vancouver. During his tenure as CEO, six companies were spun out of MPR, including PMC-Sierra and Sierra Wireless.

Prior to MPR, Alan worked for Telesat Canada, and the federal Communications Research Centre in Ottawa where he was responsible for the satellite search and rescue project (SARSAT). The international COSPAS/SARSAT system operates today and has been instrumental in saving many lives.

Alan is currently a director of the Centre for Innovation and Clean Energy. He has been a director of over 35 organizations. In 2007, he received a Leadership Award from Life Sciences BC, and in 2017 he received the Don Rix Award for Lifetime Achievement. In 2017, he also received the Bill Thompson Lifetime Achievement Award from the BC Technologies Industries Association (BC TIA). In 2023, Alan was inducted into the BC Innovators Hall of Fame.

On the federal side, he was Chair of the board of the Communications Research Centre (CRC), Deputy Chair of the Council of Science and Technology Advisors (CSTA), and a member of the Expert Panel on Research Performance and Science Funding, Council of Canadian Academies.

Alan is a Fellow of the Canadian Academy of Engineering (FCAE) and a Fellow of the American Association for the Advancement of Science (FAAAS). He is a Fellow of the Canadian Astronautics and Space Institute (FCASI) and received their inaugural Alouette team Award. Alan received his Ph.D. from Queen’s University at Kingston, Ontario and was recognized by the Queen’s alumni Legacy of Achievement. He was awarded the honorary Doctor of Science degree by Queen’s University, Belfast, in 2023.

Anne is the Managing Director of Life Sciences & Healthcare at RBCx where she leads the banks efforts in the sector across Canada. Born and raised in Toronto, Anne brings over 25 years of experience in life sciences and capital markets, with 15 years of experience within pharma and biotech. Prior to RBCx, Anne launched and led the Life Sciences and Healthcare practice in Canada for Silicon Valley Bank.

Anne is a member of the executive at Life Sciences Ontario and also sits on the board of the Ontario Biotech Innovation Organization. An active member of the Canadian life sciences community, she is a regular panelist and contributor to podcasts and various publications. Anne also offers coaching and advice to early-stage founders, reinforcing her passion for nurturing the ecosystem and enabling the next generation of changemakers to push their next breakthrough forward.

Anne holds a BSc from McGill University, an MA in leadership at the University of Guelph, and became a CFA Charterholder in 2001.